Neon drop · Free ship $75+ · Enter the grid
Signal · Product Feed

AZD 6482 Catalog No.:M10943-2 15(2)25)28-16(3)26/h12-13

SKU: 15887225211

4.7
EUR90.00 EUR136.00

Pay in 4 interest-free payments of $22.50 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Aug 13 - Aug 18

Live Spec

AZD 6482 Catalog No.:M10943-2 15(2)25)28-16(3)26/h12-13AZD6482 is a potent, selective and ATP competitive PI3K inhibitor (IC(50) 0. 01 m). AZD6482 inhibited insulin induced human adipocyte glucose uptake in vitro (IC(50) of 4. 4 m). This is the first human target validation for PI3K inhibition as anti platelet therapy showing a mild and generalized antiplatelet effect attenuating but not completely inhibiting multiple signaling pathways with an impressive separation towards primary hemostasis. AZD6482 at

Store: matisco.be · Domain: matisco.be

Description

15(2)25)28-16(3)26/h12-13

and 191 ± 1 nM for KMS-11

PubMed Central PMCID: PMC4036342

Acetazolamide

AZD 6482 Catalog No.:M10943-2 15(2)25)28-16(3)26/h12-13AZD6482 is a potent, selective and ATP competitive PI3K inhibitor (IC(50) 0. 01 m). AZD6482 inhibited insulin induced human adipocyte glucose uptake in vitro (IC(50) of 4. 4 m). This is the first human target validation for PI3K inhibition as anti platelet therapy showing a mild and generalized antiplatelet effect attenuating but not completely inhibiting multiple signaling pathways with an impressive separation towards primary hemostasis. AZD6482 at

Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products